Obicetrapib Impurity 4 | CAS 769132-67-4 - Request Quote
Obicetrapib Impurity 4
| SZ CAT No: | SZ-O083005 |
| CAS No | 769132-67-4 |
| Mol.F. | C15H19F3N2O2 |
| Mol.Wt. |
316.3 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Obicetrapib Impurity 4 is chemically ethyl 4-amino-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate. Obicetrapib Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Obicetrapib Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Obicetrapib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 769132-67-4
Purchase 769132-67-4
Order 769132-67-4
Enquire 769132-67-4
price of 769132-67-4
769132-67-4 Supplier
769132-67-4 Manufacturer
769132-67-4 Exporter
buy high quality Obicetrapib Impurity 4
Purchase Obicetrapib Impurity 4
Obicetrapib Impurity 4 suppliers
Obicetrapib Impurity 4 manufacturers
Obicetrapib Impurity 4 price
Order Obicetrapib Impurity 4
Enquire Obicetrapib Impurity 4
Obicetrapib Impurity 4 cost
Obicetrapib Impurity 4 Supplier
Obicetrapib Impurity 4 Distributor
Obicetrapib Impurity 4 for Method Validation
Obicetrapib Reference Standard
Obicetrapib Impurity 4 for ANDA Filing
Obicetrapib Impurity 4 for Forced Degradation Studies
Obicetrapib Impurity 4 Identification Standards
Obicetrapib Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.